Cinclus Pharma Holding AB (OSTO:CINPHA) YoY EBITDA Growth : -30.96% (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cinclus Pharma Holding AB's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -30.96%.

Cinclus Pharma Holding AB's EBITDA per Share for the three months ended in Mar. 2025 was kr-1.01.

Cinclus Pharma Holding AB YoY EBITDA Growth Historical Data

The historical data trend for Cinclus Pharma Holding AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB YoY EBITDA Growth Chart

Cinclus Pharma Holding AB Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

-201.76

10.41

10.90

Cinclus Pharma Holding AB Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial						30.64	30.93	41.49	-33.37	-30.96

Cinclus Pharma Holding AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cinclus Pharma Holding AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-4.242	-	-4.761)	/	\| -4.761 \|
=	10.90 %

Cinclus Pharma Holding AB's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(-1.011	-	-0.772)	/	\| -0.772 \|
=	-30.96 %

Cinclus Pharma Holding AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Cinclus Pharma Holding AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Cinclus Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

J8P:Germany

Address

Kungsbron 1, Stockholm, SWE, SE-111 22

Website

https://www.cincluspharma.com

Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines